Skip to main content
. Author manuscript; available in PMC: 2020 Dec 22.
Published in final edited form as: J Am Coll Cardiol. 2017 Oct 31;70(18):2213–2223. doi: 10.1016/j.jacc.2017.09.011

Figure 3. Cumulative incidence of endpoint events from 12–30 months after randomization, stratified by randomized treatment arm and number of anatomical complexity characteristics. MI, myocardial infarction; MACCE, major adverse cardiovascular or cerebrovascular events.

Figure 3.

Outcomes were analyzed comparing randomized treatments among subgroups of subjects with 0 (N=7824), 1 (N=3182), or 2 or more (N=548) anatomic complexity characteristics in order to assess whether treatment effects differed depending on the number of complexity factors. Relative treatment effects were consistent for the outcomes of MI or stent thrombosis and MACCE independent of the number of complexity characteristics. MI, myocardial infarction; MACCE, major adverse cardiovascular or cerebrovascular events.